Lilly LEAP Project Update & Site Tour
⚠️ EVENT UPDATE (Registered Attendees Only):
This event is at capacity, and registration is closed. Due to required advance security clearance, we cannot accommodate walk-ins, substitutions, or last-minute attendees. Only those who are pre-registered will be admitted.
Updated Event Location (for all attendees):
Ulen Country Club
100 Country Club Drive
Lebanon, IN 46052
All attendees should plan to arrive, park, and attend the education session at Ulen Country Club. Transportation to the LEAP site will be provided via bus.
Updated Schedule
7:30 – 8:00 AM – Registration, Breakfast & Networking
8:00 – 8:45 AM – Education Session
8:45 – 9:00 AM – Load Buses
9:00 – 10:30 AM – Site Tour (bus tour; returns to Ulen Country Club)
No PPE is required, as the tour will be conducted by bus.
Event Overview
Join the Indiana Construction Roundtable on Friday, June 12th for a unique, on-site learning experience at one of the largest and most significant construction projects currently underway in Indiana—the Eli Lilly & Company LEAP (Limitless Exploration/Advanced Pace) project in Lebanon.
This ICR June education event features a project update and educational briefing from Lilly, followed by a guided tour of the LEAP project site for registered participants.
Attendees will gain insight into the scale, complexity, and coordination required for a transformative megaproject, as well as its impact on Indiana’s economy and construction industry.
In 2022, Lilly announced plans to invest in two new manufacturing sites at the LEAP District. In 2024, Lilly announced it would manufacture its obesity and weight-loss drugs Mounjaro and Zepbound at Lilly Lebanon API which is anticipated to open in 2027.
On May 6, 2026, Lilly announced an additional $4.5 billion investment in the LEAP district making their total investment to date approximately $18 billion. This will be a first-hand way to learn about Indiana’s largest current capital project.
Speakers include:
- Mike DiGiovanni – Project Director for Support Facilities, Eli Lilly
- Dave Stadolnik – Project Director for Construction, Eli Lilly
IMPORTANT Reminder
Because attendee information was submitted in advance for security clearance:
- No late registrations
- No substitutions
- No additional guests
Thank you for your understanding and cooperation.
Registration is closed, as we have reached capacity for this event.
About our Speakers
Mike DiGiovanni, Eli Lilly
Mike DiGiovanni serves as Project Director, overseeing the construction and startup of the Support Facilities at Lilly’s Lebanon API site. In this role, he leads a team of project managers in collaboration with five construction management firms to deliver key site infrastructure, including a welcome center, fire station, large-scale warehouse, and a complex laboratory and administrative facility.
Mike has been with Lilly for more than 24 years and has held a range of leadership and technical roles across plant engineering, drug manufacturing operations, device assembly and manufacturing, and Global Facilities Delivery (GFD). In his prior role within GFD, he led the completion of the RTP Parenteral and Device Manufacturing Facility and subsequently directed an expansion that increased the facility’s capacity by 50 percent.
Prior to joining Lilly, Mike spent five years with Bayer Corporation in its Central Engineering Department, where he served as both a Mechanical Engineer and Project Engineer. During this time, he contributed to the design and construction of facilities supporting healthcare, petrochemical, and agricultural chemical operations.
Mike holds a Bachelor of Science degree in Mechanical Engineering, with a minor in Bioengineering, from the University of Pittsburgh.
Dave Stadolnik, Eli Lilly
Dave Stadolnik is the Project Director overseeing the construction and startup of a variety of buildings at Lilly’s Lebanon API Site. Dave and his team are developing the 606 acres in the Leap District, building the campus central utility plant, tank farm, and providing miles of distributed piping throughout the site. Also, in his responsibility includes two new manufacturing buildings to support our recently approved product Foundayo™.
Dave joined Lilly in the Spring of 2025, has been in the Life Sciences industry for over 33 years in roles including Engineering, Operations, Mergers & Acquisitions, and Quality. He has contributed to global construction projects in Europe, Singapore, and Puerto Rico.
Dave holds a bachelor’s degree in mechanical engineering from Georgia Institute of Technology.
He and his family look forward to relocating to the Indianapolis area in the next few months.